- Home
- HNST vs PBYI Comparison
HNST vs PBYI Comparison
Compare HNST & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNST | PBYI |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.9M | 263.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HNST | PBYI |
|---|---|---|
| Price | $2.81 | $5.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.33 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 2.6M | 402.3K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.87 |
| EPS | 0.06 | ★ 0.74 |
| Revenue | ★ $383,117,000.00 | $211,995,000.00 |
| Revenue This Year | $0.04 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.04 | ★ $7.87 |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $2.31 | $2.58 |
| 52 Week High | $7.49 | $6.12 |
Technical Indicators
Market Signals| Indicator | HNST | PBYI |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 66.79 |
| Support Level | $2.63 | $4.84 |
| Resistance Level | $2.98 | $5.11 |
| Average True Range (ATR) | 0.12 | 0.20 |
| MACD | 0.05 | 0.09 |
| Stochastic Oscillator | 56.25 | 93.52 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.